ATE426043T1 - Verfahren zur identifizierung des brustkrebsrisikos - Google Patents
Verfahren zur identifizierung des brustkrebsrisikosInfo
- Publication number
- ATE426043T1 ATE426043T1 AT03787201T AT03787201T ATE426043T1 AT E426043 T1 ATE426043 T1 AT E426043T1 AT 03787201 T AT03787201 T AT 03787201T AT 03787201 T AT03787201 T AT 03787201T AT E426043 T1 ATE426043 T1 AT E426043T1
- Authority
- AT
- Austria
- Prior art keywords
- breast cancer
- methods
- cancer risk
- subject
- identifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42913602P | 2002-11-25 | 2002-11-25 | |
US49023403P | 2003-07-24 | 2003-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE426043T1 true ATE426043T1 (de) | 2009-04-15 |
Family
ID=32397178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03787201T ATE426043T1 (de) | 2002-11-25 | 2003-11-25 | Verfahren zur identifizierung des brustkrebsrisikos |
Country Status (7)
Country | Link |
---|---|
US (5) | US20060204967A1 (de) |
EP (2) | EP1565582A4 (de) |
AT (1) | ATE426043T1 (de) |
AU (4) | AU2003298735A1 (de) |
CA (2) | CA2505784A1 (de) |
DE (1) | DE60326748D1 (de) |
WO (4) | WO2004047514A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7863020B2 (en) | 2000-06-28 | 2011-01-04 | Glycofi, Inc. | Production of sialylated N-glycans in lower eukaryotes |
AU2003298735A1 (en) | 2002-11-25 | 2004-06-18 | Sequenom, Inc. | Methods for identifying risk of breast cancer and treatments thereof |
WO2004048546A2 (en) * | 2002-11-25 | 2004-06-10 | Sequenom, Inc. | Methods for identifying risk of breast cancer and treatments thereof |
US20050272043A1 (en) * | 2003-07-24 | 2005-12-08 | Roth Richard B | Methods for identifying risk of breast cancer and treatments thereof |
EP1766051A4 (de) * | 2004-05-27 | 2007-10-10 | Sequenom Inc | Verfahren zur identifizierung des brustkrebsrisikos und behandlungen davon |
US20070266003A1 (en) * | 2006-05-09 | 2007-11-15 | 0752004 B.C. Ltd. | Method and system for constructing dynamic and interacive family trees based upon an online social network |
US20080163824A1 (en) * | 2006-09-01 | 2008-07-10 | Innovative Dairy Products Pty Ltd, An Australian Company, Acn 098 382 784 | Whole genome based genetic evaluation and selection process |
US20080189047A1 (en) * | 2006-11-01 | 2008-08-07 | 0752004 B.C. Ltd. | Method and system for genetic research using genetic sampling via an interactive online network |
NZ581858A (en) * | 2007-05-25 | 2012-07-27 | Decode Genetics Ehf | Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
US20090049856A1 (en) * | 2007-08-20 | 2009-02-26 | Honeywell International Inc. | Working fluid of a blend of 1,1,1,3,3-pentafluoropane, 1,1,1,2,3,3-hexafluoropropane, and 1,1,1,2-tetrafluoroethane and method and apparatus for using |
US20110311539A1 (en) * | 2007-09-17 | 2011-12-22 | Ludwig Institute For Cancer Research Ltd | Diagnosis and treatment of cancer using cancer-testis antigens |
GB2541463A (en) * | 2015-08-21 | 2017-02-22 | Univ Of Ha'il | Novel methods |
EP3478164B1 (de) * | 2016-06-29 | 2024-01-10 | Niramai Health Analytix Pvt. Ltd. | Klassifizierung des hormonrezeptorstatus von bösartigem tumorgewebe aus thermografischen bildern der brust |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
EP3607971A4 (de) * | 2017-04-05 | 2021-01-06 | National University Corporation Chiba University | Funktionshemmer von swi/snf-komplexen |
CN111190393B (zh) * | 2018-11-14 | 2021-07-23 | 长鑫存储技术有限公司 | 半导体制程自动化控制方法及装置 |
CN111383737A (zh) * | 2018-12-28 | 2020-07-07 | 康多富国际有限公司 | 癌症保健食品组合确定方法及非瞬时计算机可读存储介质 |
CN111383736A (zh) * | 2018-12-28 | 2020-07-07 | 康多富国际有限公司 | 免疫系统疾病保健食品组合确定方法及其可读取储存媒体 |
US10851376B2 (en) * | 2018-12-28 | 2020-12-01 | The Florida International University Board Of Trustees | Long noncoding RNAs in pulmonary airway inflammation |
WO2024148280A1 (en) | 2023-01-06 | 2024-07-11 | Ideaya Biosciences, Inc. | Treatment of er+ breast cancer comprising homologous recombination deficiency using parc inhibitor |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE68928242T2 (de) | 1988-07-08 | 1997-12-18 | Chiron Corp | Gap-gen-sequenzen und diagnoseverwendungen davon |
US5359078A (en) * | 1989-05-19 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor compounds |
US6013431A (en) * | 1990-02-16 | 2000-01-11 | Molecular Tool, Inc. | Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators |
EP0672140B1 (de) * | 1992-11-12 | 2003-02-26 | MERCK SHARP & DOHME LTD. | Transfektierte zelllinie, exprimierend dns die für die nmda-r2a rezeptor untereinheit und für isoformen der nmda-r1 untereinheit des menschlichen nmda-rezeptors kodieren |
JPH08509857A (ja) * | 1993-01-07 | 1996-10-22 | シーケノム・インコーポレーテッド | マススペクトロメトリーによるdna配列決定法 |
US5605798A (en) * | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
US6194144B1 (en) * | 1993-01-07 | 2001-02-27 | Sequenom, Inc. | DNA sequencing by mass spectrometry |
WO1995014108A1 (en) * | 1993-11-17 | 1995-05-26 | Amersham International Plc | Primer extension mass spectroscopy nucleic acid sequencing method |
US5869242A (en) * | 1995-09-18 | 1999-02-09 | Myriad Genetics, Inc. | Mass spectrometry to assess DNA sequence polymorphisms |
US5928906A (en) * | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
US6432668B1 (en) | 1997-12-30 | 2002-08-13 | Chiron Corporation | Polynucleotides encoding human cyclin-dependent kinase (hPFTAIRE) |
US20020182599A1 (en) * | 2000-01-12 | 2002-12-05 | Fishman Mark C | Methods for diagnosing and treating heart disease |
AU2001288999A1 (en) * | 2000-09-08 | 2002-03-22 | Millennium Pharmaceuticals, Inc. | 38646, a guanine nucleotide exchange factor and uses therefor |
US20020155440A1 (en) * | 2000-12-19 | 2002-10-24 | Ljubimova Julia Y. | Using overexpression of laminin alpha 4 subunit as a diagnostic and prognostic indicator of malignant tumors |
US20030022191A1 (en) | 2001-01-08 | 2003-01-30 | Lotfi Chouchane | Method of identifying and managing increased risk of breast carcinoma associated with polymorphisms in MHC genes |
AU2003298735A1 (en) | 2002-11-25 | 2004-06-18 | Sequenom, Inc. | Methods for identifying risk of breast cancer and treatments thereof |
WO2004048546A2 (en) * | 2002-11-25 | 2004-06-10 | Sequenom, Inc. | Methods for identifying risk of breast cancer and treatments thereof |
US20050272043A1 (en) * | 2003-07-24 | 2005-12-08 | Roth Richard B | Methods for identifying risk of breast cancer and treatments thereof |
WO2006062716A2 (en) | 2004-11-18 | 2006-06-15 | Yale University | Methods and compositions for treating ocular disorders |
WO2006096561A2 (en) | 2005-03-04 | 2006-09-14 | Duke University | Genetic variants increase the risk of age-related macular degeneration |
WO2006096737A2 (en) | 2005-03-07 | 2006-09-14 | The Trustees Of Boston University | Diagnostic and therapeutic target for macular degeneration |
-
2003
- 2003-11-25 AU AU2003298735A patent/AU2003298735A1/en not_active Abandoned
- 2003-11-25 AU AU2003293141A patent/AU2003293141A1/en not_active Abandoned
- 2003-11-25 CA CA002505784A patent/CA2505784A1/en not_active Abandoned
- 2003-11-25 WO PCT/US2003/037943 patent/WO2004047514A2/en not_active Application Discontinuation
- 2003-11-25 EP EP03796494A patent/EP1565582A4/de not_active Withdrawn
- 2003-11-25 EP EP03787201A patent/EP1565579B1/de not_active Expired - Lifetime
- 2003-11-25 US US10/723,683 patent/US20060204967A1/en not_active Abandoned
- 2003-11-25 WO PCT/US2003/037831 patent/WO2004055196A2/en not_active Application Discontinuation
- 2003-11-25 CA CA2505786A patent/CA2505786C/en not_active Expired - Fee Related
- 2003-11-25 US US10/722,939 patent/US20050214771A1/en not_active Abandoned
- 2003-11-25 DE DE60326748T patent/DE60326748D1/de not_active Expired - Lifetime
- 2003-11-25 AT AT03787201T patent/ATE426043T1/de not_active IP Right Cessation
- 2003-11-25 WO PCT/US2003/037948 patent/WO2004047623A2/en not_active Application Discontinuation
- 2003-11-25 US US10/723,681 patent/US7510835B2/en not_active Expired - Fee Related
- 2003-11-25 AU AU2003295986A patent/AU2003295986A1/en not_active Abandoned
- 2003-11-25 WO PCT/US2003/037966 patent/WO2004047767A2/en not_active Application Discontinuation
- 2003-11-25 US US10/723,142 patent/US20050053958A1/en not_active Abandoned
- 2003-11-25 AU AU2003302732A patent/AU2003302732A1/en not_active Abandoned
-
2009
- 2009-03-09 US US12/400,724 patent/US20090317816A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004047767A3 (en) | 2005-04-14 |
AU2003302732A8 (en) | 2004-07-09 |
EP1565579A2 (de) | 2005-08-24 |
DE60326748D1 (de) | 2009-04-30 |
US7510835B2 (en) | 2009-03-31 |
US20050214771A1 (en) | 2005-09-29 |
CA2505784A1 (en) | 2004-06-10 |
AU2003298735A1 (en) | 2004-06-18 |
US20060204967A1 (en) | 2006-09-14 |
WO2004055196A3 (en) | 2005-02-24 |
WO2004047623A2 (en) | 2004-06-10 |
WO2004047767A2 (en) | 2004-06-10 |
WO2004055196A2 (en) | 2004-07-01 |
AU2003302732A1 (en) | 2004-07-09 |
EP1565579B1 (de) | 2009-03-18 |
AU2003295986A1 (en) | 2004-06-18 |
CA2505786C (en) | 2011-06-21 |
EP1565582A4 (de) | 2006-06-07 |
WO2004047514A2 (en) | 2004-06-10 |
EP1565579A4 (de) | 2007-02-14 |
CA2505786A1 (en) | 2004-06-10 |
AU2003293141A1 (en) | 2004-06-18 |
US20090317816A1 (en) | 2009-12-24 |
EP1565582A2 (de) | 2005-08-24 |
WO2004047623A3 (en) | 2004-10-14 |
WO2004047514A3 (en) | 2004-11-04 |
AU2003293141A8 (en) | 2004-06-18 |
US20050053958A1 (en) | 2005-03-10 |
US20050192239A1 (en) | 2005-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60326748D1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
ATE437962T1 (de) | Verfahren für die behandlung von proliferativen erkrankungen von brustzellen | |
WO2005014846A3 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
ATE410524T1 (de) | Verfahren und nukleinsäuren für die analyse von zellulären proliferationsstörungen | |
ATE470723T1 (de) | Genexpressionsmarker für die prognose von brustkrebs | |
WO2004043232A3 (en) | Methods for identifying risk of melanoma and treatments thereof | |
ATE456666T1 (de) | Verfahren zur auswertung von ribonukleotidsequenzen | |
WO2005059108A3 (en) | Gene expression profiles and methods of use | |
ATE476525T1 (de) | Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern | |
DE602004015626D1 (de) | Bei brustkrebs | |
WO2004078035A3 (en) | Expression profiles for breast cancer and methods of use | |
ATE397098T1 (de) | Verfahren zur diagnostik von eierstock endometriose | |
WO2005027710A3 (en) | Methods for identifying subjects at risk of melanoma and treatments thereof | |
ES2175095T3 (es) | Marcadores de adn respecto al tamaño de una camada de cerdos. | |
WO2006022619A3 (en) | Methods for identifying risk of type ii diabetes and treatments thereof | |
WO2004048546A3 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
ATE494390T1 (de) | Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen | |
ATE449323T1 (de) | Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren | |
MXPA05006034A (es) | Proteina de duplicacion. | |
WO2005118834A3 (en) | Methods for identifying risk of breast cancer and treatment thereof | |
WO2006063285A3 (en) | Methods for identifying risk of breast cancer or prostate cancer and treatments thereof | |
WO2004048548A3 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
DE60216416D1 (de) | Verfahren zum nachweis von chloralhydrat in dichloressigsäure | |
DE60218995D1 (de) | Verfahren zur kit genotypierung von schweinen | |
NZ584656A (en) | Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |